Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/16380544
Conclusion of this study
Although previously overlooked, homocysteine is highly responsive to riboflavin, specifically in individuals with the MTHFR 677 TT genotype. Our findings might explain why this common polymorphism carries an increased risk of coronary heart disease in Europe but not in North America, where riboflavin fortification has existed for >50 years.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
Body systems related to this study
Cardiovascular System |